Liver cancer presents unique challenges for early detection, as initial symptoms often appear subtle or mimic common ailments ...

Sino Biopharmaceutical (HK:1177) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Penpulimab in combination therapy for the first-line treatment of metastatic NPC, has had its marketing application accepted by the NMPA and the FDA. Additionally, the marketing application for its ...

Whakatāne man Rhys Drayson was hunting in the bush when he decided to swing on a vine. But it ended in disaster with a broken ...

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

According to the NHS, most patients are diagnosed too late for them to receive the required treatment. Joseph Ambani, a Medical Doctor at GlowBar, has revealed the "first" sign of liver cancer to ...

Given the increasing prevalence and mortality rates, targeted strategies are needed to reduce this growing health burden in ...

Christopher Burge is one of a growing number of young adults diagnosed with the disease, and hopes to spread awareness about the early signs.

Whakatāne man Rhys Drayson was diagnosed with liver cancer in 2022 after he developed hepatitis C from a blood transfusion in ...

“Detecting cancer early results in less aggressive treatment and a higher chance of recovery. Some screening tests can detect ...